Overview
- A Lancet Diabetes & Endocrinology analysis of 894 young patients showed that 65% in three sub-Saharan African countries had no islet autoantibodies or genetic risk markers for type 1 diabetes
- Comparative U.S. data revealed 15% of Black Americans diagnosed with type 1 diabetes exhibit the same nonautoimmune subtype, while White Americans retain typical autoimmune genetic profiles
- Patients with the novel form displayed higher endogenous insulin secretion and lacked features of type 2 or malnutrition-related diabetes, indicating a distinct insulin-deficient disease
- Researchers warn that reliance on autoantibody testing and Western-based genetic scores may misclassify up to two-thirds of African youth, leading to suboptimal insulin management
- Experts are calling for expanded studies into the biological and environmental drivers of this subtype and for updated, region-specific screening and treatment guidelines